These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24899337)

  • 1. Blood transfusion in obstetrics.
    Nigam A; Prakash A; Saxena P
    Kathmandu Univ Med J (KUMJ); 2013; 11(44):355-9. PubMed ID: 24899337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review.
    McQuilten ZK; Crighton G; Brunskill S; Morison JK; Richter TH; Waters N; Murphy MF; Wood EM
    Transfus Med Rev; 2018 Jan; 32(1):6-15. PubMed ID: 28803752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usage of blood components in obstetrics.
    Adukauskienė D; Veikutienė A; Adukauskaitė A; Veikutis V; Rimaitis K
    Medicina (Kaunas); 2010; 46(8):561-7. PubMed ID: 20966634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study to investigate fresh frozen plasma and packed cell ratios when administered for women with postpartum hemorrhage, before and after introduction of a massive transfusion protocol.
    Weiniger CF; Yakirevich-Amir N; Sela HY; Gural A; Ioscovich A; Einav S
    Int J Obstet Anesth; 2018 Nov; 36():34-41. PubMed ID: 30245260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of fresh frozen plasma in surgery with special reference to autologous fresh frozen plasma].
    Heim MU; Mempel W
    Infusionstherapie; 1990 Apr; 17 Suppl 2():34-6. PubMed ID: 2373546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive Transfusion Protocols in Obstetric Hemorrhage: Theory versus Reality.
    Salmanian B; Clark SL; Hui SR; Detlefs S; Aalipour S; Meshinchi Asl N; Shamshirsaz AA
    Am J Perinatol; 2023 Jan; 40(1):95-98. PubMed ID: 33990124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Ratio of Fresh Frozen Plasma to Red Blood Cells During Massive Transfusion and Survival Among Patients Without Traumatic Injury.
    Mesar T; Larentzakis A; Dzik W; Chang Y; Velmahos G; Yeh DD
    JAMA Surg; 2017 Jun; 152(6):574-580. PubMed ID: 28273299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications of the different components of blood and outcome of transfusion practices in postpartum hemorrhage].
    Ricat R; Palot M
    Cah Anesthesiol; 1994; 42(3):385-9. PubMed ID: 7812867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation.
    Rosenberg EM; Chambers LA; Gunter JM; Good JA
    Pediatrics; 1994 Sep; 94(3):341-6. PubMed ID: 8065860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on transfusion medicine.
    Shander A; Goodnough LT
    Pharmacotherapy; 2007 Sep; 27(9 Pt 2):57S-68S. PubMed ID: 17723109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Targeted Cell Salvage Blood Transfusion During Cesarean Delivery With Allogeneic Packed Red Blood Cell Transfusions in a Maternity Hospital in China.
    Yan H; Hu LQ; Wu Y; Fan Q; Wong CA; McCarthy RJ
    Anesth Analg; 2018 Sep; 127(3):706-713. PubMed ID: 29505447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous transfusion for patients with increased risk of massive and/or critical bleeding--indication, efficacy and limitations].
    Yoshiba F
    Masui; 2011 Jan; 60(1):40-6. PubMed ID: 21348249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of an obstetric cell salvage service in a tertiary women's hospital.
    Lew E; Tagore S
    Singapore Med J; 2015 Aug; 56(8):445-9. PubMed ID: 26311910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric non-red cell blood product transfusion practices: what's the evidence to guide transfusion of the 'yellow' blood products?
    Steinbicker AU; Wittenmeier E; Goobie SM
    Curr Opin Anaesthesiol; 2020 Apr; 33(2):259-267. PubMed ID: 32049883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
    Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.
    Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S
    Vox Sang; 2015 Apr; 108(3):243-50. PubMed ID: 25536173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center.
    Dente CJ; Shaz BH; Nicholas JM; Harris RS; Wyrzykowski AD; Patel S; Shah A; Vercruysse GA; Feliciano DV; Rozycki GS; Salomone JP; Ingram WL
    J Trauma; 2009 Jun; 66(6):1616-24. PubMed ID: 19509623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal outcomes following postpartum autotransfusion of blood lost during vaginal obstetric hemorrhage.
    Phillips JM; Larkin J; Waters JH; Tamura T; Sakamoto S
    Transfusion; 2024 Jan; 64(1):77-84. PubMed ID: 37997677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous platelet-rich plasma reduces transfusions during ascending aortic arch repair: a prospective, randomized, controlled trial.
    Zhou SF; Estrera AL; Loubser P; Ignacio C; Panthayi S; Miller C; Sheinbaum R; Safi HJ
    Ann Thorac Surg; 2015 Apr; 99(4):1282-90. PubMed ID: 25661906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative blood and blood component therapy.
    Irving GA
    Can J Anaesth; 1992 Dec; 39(10):1105-15. PubMed ID: 1464138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.